Skip to main content
Loading market data...
ETF Nasdaq USD

iShares Biotechnology ETF IBB

Issuer: iShares SEC registrant: iShares Trust Equity · Global
Watch IBB (sign in) Add to portfolio (IBB) Set an alert for IBB Compare IBB with other ETFs Position size calculator for IBB at 210.5 USD

How position sizing works
Last price 210.50 USD Change: Up +6.44 Percent change: Up +3.16%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.44%
Prospectus 1 Aug 2025
Net assets
$9.1B
As of 30 Jun 2026
Holdings
252
As of 30 Jun 2026
12-month distribution yield
0.16%
Quarterly
Asset class
Equity
From holdings

iShares Biotechnology ETF (IBB) is an exchange-traded fund listed on the Nasdaq in the United States, issued by iShares. Its category is Equity · Global (equity). Its last price was US$210.50 on 20 Oct 2026. Its expense ratio is 0.44% a year, from its prospectus dated 1 Aug 2025. It reported net assets of US$9.09 billion as of 30 Jun 2026. Its latest holdings report lists 252 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$0.34 a unit, a 12-month distribution yield of 0.16%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.44%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.44%
Prospectus date
1 Aug 2025
Filed with the SEC
22 Jul 2025

Source: SEC prospectus risk/return data sets (opens in a new tab) Filed

Size and reporting

Net assets
$9,087,528,995
Total assets
$10,151,979,589
Holdings as of
30 Jun 2026
Report made public
25 Aug 2026 (56 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Source: SEC Form N-PORT (opens in a new tab) Filed

Top holdings

Largest 25 of 252 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.

IBB top holdings as of 30 Jun 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 BlackRock Funds III BlackRock Cash Funds: Institutional, SL Agency Shares US0669225197 11.66% $1.1B Short-term investment vehicles (cash funds) United States USD
2 Vertex Pharmaceuticals, Inc. US92532F1003 8.08% $734.3M Equity (common) United States USD
3 Amgen, Inc. US0311621009 7.83% $711.4M Equity (common) United States USD
4 Gilead Sciences, Inc. US3755581036 6.84% $621.8M Equity (common) United States USD
5 Regeneron Pharmaceuticals, Inc. US75886F1075 4.91% $445.9M Equity (common) United States USD
6 Argenx SE US04016X1019 3.76% $341.6M Equity (common) Netherlands USD
7 Alnylam Pharmaceuticals, Inc. US02043Q1076 3.12% $283.6M Equity (common) United States USD
8 Natera, Inc. US6323071042 2.89% $262.7M Equity (common) United States USD
9 Revolution Medicines, Inc. US76155X1000 2.78% $252.7M Equity (common) United States USD
10 Biogen, Inc. US09062X1037 2.47% $224.1M Equity (common) United States USD
11 Illumina, Inc. US4523271090 2.07% $188.0M Equity (common) United States USD
12 Moderna, Inc. US60770K1079 1.98% $180.3M Equity (common) United States USD
13 Insmed, Inc. US4576693075 1.78% $162.2M Equity (common) United States USD
14 BeOne Medicines Ltd. US07725L1026 1.77% $160.8M Equity (common) Switzerland USD
15 Incyte Corp. US45337C1027 1.75% $159.0M Equity (common) United States USD
16 United Therapeutics Corp. US91307C1027 1.73% $157.6M Equity (common) United States USD
17 Roivant Sciences Ltd. BMG762791017 1.43% $129.6M Equity (common) Bermuda USD
18 Neurocrine Biosciences, Inc. US64125C1099 1.30% $118.0M Equity (common) United States USD
19 Ascendis Pharma A/S DK0060615755 1.29% $116.9M Equity (common) Denmark USD
20 Genmab A/S US3723032062 1.12% $101.7M Equity (common) Denmark USD
21 Exelixis, Inc. US30161Q1040 1.03% $93.9M Equity (common) United States USD
22 Ionis Pharmaceuticals, Inc. US4622221004 1.00% $91.1M Equity (common) United States USD
23 Bridgebio Pharma, Inc. US10806X1028 0.98% $89.2M Equity (common) United States USD
24 Medpace Holdings, Inc. US58506Q1094 0.95% $86.3M Equity (common) United States USD
25 Madrigal Pharmaceuticals, Inc. US5588681057 0.91% $82.5M Equity (common) United States USD

Source: SEC Form N-PORT (opens in a new tab) Made public Holdings as of 30 Jun 2026

All 252 stored holdings

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 99.88%
Short-term investment vehicles (cash funds) 12.04%
Other <0.01%
Equity derivatives <0.01%

Country

Country by weight
CountryWeightBar
United States 96.35%
Netherlands 4.25%
Denmark 2.40%
Switzerland 2.17%
Bermuda 1.43%
Canada 1.16%
Cayman Islands 0.87%
Ireland 0.80%
France 0.68%
Germany 0.66%
United Kingdom 0.28%
British Virgin Islands 0.15%
Other (8) 0.72%

The country each issuer is assigned to in the report.

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 111.92%

The currency each holding is denominated in. Currency hedges are not netted off, so a hedged fund still shows its holdings' currencies.

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 76.38%
Health Technology 1.47%
Industrials 0.52%
Technology 0.48%

Partial coverage: sectors are known for 78.9% of net assets (79% of the fund's equity weight), the holdings matched by CUSIP or ticker to US stocks listed on this site. The rest is not assigned a sector.

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.3400
4 payments per unit
12-month yield
0.16%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
15 Sep 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.3400) ÷ latest price ($210.50) × 100 = 0.16%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (18 payments)
IBB distributions per unit by ex-date
Ex-dateAmount per unit
15 Sep 2026$0.0110
15 Jun 2026$0.0240
17 Mar 2026$0.1220
16 Dec 2025$0.1830
16 Sep 2025$0.0830
18 Mar 2025$0.1210
17 Dec 2024$0.0620
25 Sep 2024$0.2000
21 Mar 2024$0.1260
20 Dec 2023$0.1240
26 Sep 2023$0.1530
7 Jun 2023$0.0060
23 Mar 2023$0.0650
13 Dec 2022$0.1010
26 Sep 2022$0.1590
9 Jun 2022$0.0310
24 Mar 2022$0.1180
13 Dec 2021$0.0410

Source: Yahoo Finance (opens in a new tab) Checked · 2 days ago Amounts are adjusted for later unit splits

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources
    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Region and currency: automatic

    Prices stay in each listing's own currency. Your currency is used for totals and for "≈" estimates at the daily reference rate. How this works

    Colour theme